The Discovery of Penicillin: Medicine's Greatest Accident
In September 1928, a Scottish bacteriologist returned from a summer holiday to find a petri dish contaminated with mold. Most scientists would have thrown it away. Alexander Fleming looked closer — and noticed something extraordinary. The mold had killed the bacteria surrounding it, creating a clear ring of death in the bacterial colony. That observation would lead to the development of penicillin, the world's first antibiotic, which has saved an estimated 200 million lives and fundamentally transformed medicine.
The World Before Antibiotics
It is difficult for modern people to grasp how terrifying infectious disease was before antibiotics. A scratch from a rose thorn could lead to a fatal infection. A child's ear infection could spread to the brain and kill within days. Childbirth was dangerous partly because of puerperal fever — a bacterial infection that killed countless mothers.
During World War I, more soldiers died from infected wounds than from the wounds themselves. Even minor injuries — shrapnel fragments, bullet grazes — often led to sepsis, gangrene, and death. The antiseptics available (carbolic acid, iodine) damaged tissue as much as they killed bacteria.
Surgeons could cut and suture with increasing sophistication, but they had no way to fight bacterial infection once it took hold. Pneumonia, tuberculosis, scarlet fever, and gonorrhea were frequently fatal. Life expectancy in the early 20th century hovered around 47 years in the United States — and infectious disease was the leading cause of death.
Fleming's Lucky Observation
Alexander Fleming (1881–1955) was a researcher at St. Mary's Hospital in London, studying staphylococcus bacteria — the common "staph" that caused wound infections. He was known among colleagues as a gifted but somewhat untidy scientist.
In early September 1928, Fleming returned from vacation and began sorting through the petri dishes he had left on his bench. One dish had been contaminated by a Penicillium mold — likely blown in through an open window from a mycology lab on the floor below. The mold had produced a substance that clearly inhibited the growth of the staphylococci.
"One sometimes finds what one is not looking for. When I woke up just after dawn on September 28, 1928, I certainly didn't plan to revolutionize all medicine by discovering the world's first antibiotic. But I suppose that was exactly what I did." — Alexander Fleming
Fleming investigated further. He grew the mold in a broth and found that the liquid — which he called "penicillin" — killed a range of disease-causing bacteria, including streptococci and the bacteria responsible for diphtheria, gonorrhea, and meningitis. Crucially, it was far less toxic to human tissue than the antiseptics then in use.
Fleming published his findings in the British Journal of Experimental Pathology in June 1929. The paper received almost no attention.
The Problem of Production
Fleming recognized penicillin's potential but could not solve the practical problem of producing it in quantity. The mold produced only tiny amounts of the active substance, and Fleming — a bacteriologist, not a chemist — lacked the expertise to purify and concentrate it. After a few years of sporadic effort, he moved on to other work.
Penicillin might have remained a laboratory curiosity were it not for two scientists at the University of Oxford: Howard Florey, an Australian-born pathologist, and Ernst Boris Chain, a German-Jewish biochemist who had fled Nazi Germany.
In 1939, Florey and Chain revisited Fleming's work and began systematically attempting to purify penicillin and produce it in quantities sufficient for clinical use. The task was formidable. The mold grew slowly, the yields were tiny, and the active compound was unstable.
The Oxford Miracle
Florey's team improvised brilliantly. They grew the mold in an astonishing array of containers — bedpans, milk churns, ceramic vessels, and eventually custom-built fermentation tanks. Norman Heatley, a biochemist on the team, developed extraction techniques using back-extraction between water and organic solvents.
The first clinical test came on February 12, 1941. A policeman named Albert Alexander had scratched his face on a rose bush; the scratch had become infected, and he was dying of sepsis. After receiving penicillin injections, Alexander improved dramatically within 24 hours. But the supply ran out after five days — the team was so desperate that they recycled penicillin extracted from Alexander's urine. The infection returned, and Alexander died on March 15.
The outcome was heartbreaking but scientifically encouraging: penicillin worked, but they needed vastly more of it.
American Mass Production
Florey traveled to the United States in 1941, seeking American industrial help to mass-produce penicillin. He found an ally at the USDA's Northern Regional Research Laboratory in Peoria, Illinois, where scientists discovered that growing the mold in deep fermentation tanks using corn steep liquor (a waste product from corn processing) dramatically increased yields.
A worldwide search for more productive Penicillium strains led to a remarkable find: a moldy cantaloupe from a Peoria fruit market yielded a strain (Penicillium chrysogenum) that produced far more penicillin than Fleming's original mold. This strain, subjected to repeated mutation and selection using ultraviolet radiation and X-rays, became the ancestor of all industrial penicillin production.
By D-Day (June 6, 1944), American pharmaceutical companies — including Pfizer, Merck, and Squibb — were producing enough penicillin to treat every wounded Allied soldier. Production had increased from essentially zero in 1941 to 650 billion units per month by 1945.
The Impact
Penicillin's impact on medicine was revolutionary. Diseases that had been death sentences — bacterial pneumonia, scarlet fever, wound infections, syphilis, gonorrhea — became treatable. Surgical mortality plummeted, because post-operative infections could be controlled. Life expectancy began its dramatic climb.
Fleming, Florey, and Chain shared the Nobel Prize in Physiology or Medicine in 1945. Fleming became a global celebrity — though Florey and Chain (and the often-overlooked Heatley) arguably deserved more credit for transforming Fleming's observation into a usable drug.
The Antibiotic Era — and Its Dangers
Penicillin launched the antibiotic era. Streptomycin (1944), tetracycline (1948), erythromycin (1952), and many other antibiotics followed, giving doctors an arsenal against bacterial disease that previous generations could not have imagined.
But Fleming himself sounded an early warning. In his 1945 Nobel lecture, he cautioned that bacteria could develop resistance to penicillin if it was used carelessly — if doses were too low or courses too short. His prediction has proven grimly accurate.
Today, antibiotic resistance is one of the greatest threats to global health. Bacteria that are resistant to multiple antibiotics — "superbugs" like MRSA (methicillin-resistant Staphylococcus aureus) — kill an estimated 1.27 million people worldwide each year. The overuse of antibiotics in human medicine and agriculture has accelerated resistance, and the pipeline of new antibiotics has slowed to a trickle.
The story of penicillin is a reminder of both the power and the fragility of medical progress. A chance observation, a contaminated petri dish, and years of painstaking work gave humanity its most powerful weapon against infectious disease. Whether we can preserve that weapon for future generations is one of the defining challenges of our time.
